Clotrimazole farmakopea Cream Derm 30g 1%

NAME
CLOTRIMAZOLE FARMAKOPEA 1% CREAM

PHARMACOTHERAPEUTIC CATEGORY
Topical antifungals.

ACTIVE PRINCIPLES
Clotrimazole 1 g / 100 g.

EXCIPIENTS
Sorbitan monostearate, polysorbate 60, cetyl palmitate, cetostearyl alcohol, octyldodecanol, benzyl alcohol, purified water.

INDICATIONS
Mycosis of the skin and skin folds, such as pityriasis versicolor, skin candidiasis, tinea pedis or athlete's foot, tinea corporis.

CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance or to any of the excipients.

DOSAGE
Apply in small quantities two-three times a day in correspondence with the affected area, rubbing lightly, after having carefully washed and dried the part. Half a cm of cream is enough to treat a surface the size of a hand. The cream is electively indicated for the treatment of hairless (hairless) skin areas. Generally for the disappearance of the manifestations, a treatment period without interruption of three to four weeks is sufficient. In order to consolidate the therapeutic results obtained and avoid reinfections, it is advisable to continue the therapy with Clotrimazole for at least two weeks after the disappearance of the manifestations. To avoid relapses, very common in mycosis, it is good to inform the patient that he must observe some elementary hygiene rules: frequent change of underwear, towels and their chemical or thermal disinfection; avoid promiscuity of clothes and linen.

STORAGE
This medicine does not require any special storage conditions.

WARNINGS
Avoid contact with eyes. Do not swallow. The use, especially if prolonged, of products for topical use can give rise to sensitization phenomena. In diaper dermatitis, we do not recommend the use of diapers with an occlusive effect after applying the cream. The cream contains cetostearyl alcohol which can cause local skin reactions (eg contact dermatitis).

INTERACTIONS
None known.

SIDE EFFECTS
The adverse reactions listed below derive from spontaneous reports and therefore an organization by frequency categories is not possible. Immune system disorders: allergic reaction (syncope, hypotension, dyspnoea, urticaria). Skin and subcutaneous tissue disorders: blisters, discomfort / pain, edema, irritation, peeling, itching, rash, burning.

PREGNANCY AND BREASTFEEDING
Although no controlled clinical studies have been performed in pregnant women, epidemiological investigations indicate the absence of harmful effects of clotrimazole treatment on mother and baby. However, as for all medicines, in the first trimester of pregnancy the product should be administered only in case of real need '.